{
  "pmcid": "2893586",
  "sha256": "4471c3776afd08d625a7ea8b11b4c9323602da95d8a5cfbca0e5ede3ffd1bd72",
  "timestamp_utc": "2025-11-09T22:35:01.738181+00:00",
  "model_used": "gpt-4o",
  "readability": {
    "flesch_kincaid": 13.167842975206618,
    "reading_ease": 22.207219008264474,
    "word_count": 242
  },
  "consort_scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "Randomised Controlled Trial of Stereotactic Radiosurgery in Facilitating Microsurgical Resection of Brain Arteriovenous Malformations"
      },
      "Trial_Design": {
        "score": 1,
        "evidence": "In this randomised controlled trial, 42 patients with AVMs were recruited"
      },
      "Participants": {
        "score": 2,
        "evidence": "42 patients with AVMs were recruited at the University of California, San Francisco, between 1997 and 2007"
      },
      "Intervention": {
        "score": 2,
        "evidence": "Participants were randomly assigned to receive either prior RS (RS+) or no RS (RSâˆ’) before microsurgical resection"
      },
      "Objective": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Method_Outcome": {
        "score": 1,
        "evidence": "The primary outcome was the change in modified Rankin Scale (mRS) scores, assessed postoperatively"
      },
      "Randomisation_Allocation": {
        "score": 2,
        "evidence": "Randomisation was performed using a computer-generated sequence, and allocation was concealed using sealed envelopes"
      },
      "Blinding": {
        "score": 1,
        "evidence": "Outcome assessors were blinded to group allocation"
      },
      "Number_Randomised": {
        "score": 1,
        "evidence": "A total of 21 patients were randomised to each group"
      },
      "Number_Analysed": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Result_Outcome": {
        "score": 2,
        "evidence": "Mean AVM volume was reduced by 78% in the RS+ group (P<0.01), and Spetzler-Martin grades decreased in 52% of RS+ patients (P<0.001)"
      },
      "Harms": {
        "score": 1,
        "evidence": "RS+ patients experienced deterioration due to hemorrhages during the latency period (P<0.05)"
      },
      "Trial_Registration": {
        "score": 0,
        "evidence": "Trial registration: [Trial registration number]"
      },
      "Funding": {
        "score": 0,
        "evidence": "Funding: [Source of funding]"
      }
    },
    "total_score": 14,
    "max_score": 25
  }
}